Statin treatment may curb Alzheimer's brain changes

People who take statin drugs may be less likely to develop the brain changes that signal Alzheimer's disease, according to a study published in the August 28, 2007, issue of Neurology, the medical journal of the American Academy of Neurology.

Previous research had suggested that people who received statins might be less likely to develop Alzheimer’s disease. “But our study is the first to compare the brains of people who had received statins with those who had not,” said Gail (Ge) Li, MD, PhD. The paper's lead author, Dr. Li is an assistant professor of psychiatry and behavioral sciences at the University of Washington School of Medicine, in Seattle.

She and her colleagues examined the brains of 110 Group Health members, aged 65 to 79, who had participated in Adult Changes in Thought (ACT) and who donated their brains for research. A joint project of Group Health and the University of Washington, ACT is a prospective cohort study started in 1994. It includes a random sample of Group Health members age 65 and older who had no thinking difficulties when enrolled.

The two changes in the brain that are considered the most definitive hallmarks of Alzheimer’s are brain “plaques” and “tangles.” After controlling for variables including age at death, gender, and strokes in the brain, the researchers found significantly fewer tangles in the brains of people who had taken statins than in those who had not. “These results are exciting, novel, and have important implications for prevention strategies,” said senior co-author Eric Larson, MD, MPH, the leader of the ACT study and executive director of Group Health Center for Health Studies. “But they need to be confirmed, because ACT is not a randomized controlled trial.”

A randomized controlled trial of statin treatment and brain autopsy findings would be problematic for ethical and practical reasons, said Dr. Larson. But the ACT setting made the study more rigorous than previous observational epidemiological studies, because it uses reliable automated pharmacy records, is based in a community population, and includes autopsies in people both with and without dementia.

Statins (HMG coenzyme A reductase inhibitors), include atorvastatin (Lipitor), lovastatin (Mevacor), rosuvastatin (Crestor), and simvastatin (Zocor). They are widely prescribed to lower cholesterol of people who have heart disease or are at risk for it. Randomized controlled trials are testing some statins, especially those that cross the barrier between the blood and the brain, for their ability to prevent or treat Alzheimer’s disease.

“People with Alzheimer’s are diverse,” said Dr. Li. “Statins are probably more likely to help prevent the disease in certain kinds of people than others.” Larson adds, “Someday we may be able to know more precisely which individuals will benefit from which types of statins for preventing the changes of Alzheimer’s disease.”

Source: Group Health Cooperative Center for Health Studies

Related stories:

Seniors with type 2 diabetes may experience memory declines immediately after eating unhealthy meal
Adults with type 2 diabetes who eat unhealthy, high-fat meals may experience memory declines immediately afterward, but this can be offset by taking antioxidant vitamins with the meal, according to new research from Baycrest.
Memory loss linked to common sleep disorder
For the first time, UCLA researchers have discovered that people with sleep apnea show tissue loss in brain regions that help store memory. Reported in the June 27 edition of the journal Neuroscience Letters, the findings emphasize the importance of early detection of the disorder, which afflicts an estimated 20 million Americans.
Ibuprofen, aspirin, naproxen may be equally effective at reducing risk of Alzheimer's disease
Different types of non-steroidal anti-inflammatory drugs (NSAIDs), such as ibuprofen, naproxen, and aspirin, appear to be equally effective in lowering the risk of Alzheimer’s disease, according to the largest study of its kind published in the May 28, 2008, online issue of Neurology, the medical journal of the American Academy of Neurology. Experts have debated whether a certain group of NSAIDs that includes ibuprofen may be more beneficial than another group that includes naproxen and aspirin.
Researchers explore the emerging role of infection in Alzheimer's disease
The realization that pathogens can produce slowly progressive chronic diseases has opened new lines of research into Alzheimer's disease. In a special issue of the Journal of Alzheimer's Disease published May 2008, guest editors Judith Miklossy, from the University of British Columbia, and Ralph N. Martins, from Edith Cowan University and Hollywood Private Hospital, Perth, Western Australia, and a group of experts explore this exciting topic.
Green tea compounds beat OSA-related brain deficits
Chemicals found in green tea may be able to stave off the cognitive deficits that occur with obstructive sleep apnea (OSA), according to a new study published in the second issue for May of the American Thoracic Society’s American Journal of Respiratory and Critical Care Medicine.
Obesity can increase dementia risk by up to 80 percent
Being obese can increase the risk of Alzheimer’s Disease by as much as 80 per cent, according to a study in the May issue of Obesity Reviews.
Study in mice suggests molecules in plants have beneficial effect on Alzheimer's disease
A set of molecules found in certain plants appears to have a beneficial effect in brain tissue associated with Alzheimer’s disease, according to a new study conducted in mice. The study was led by researchers at the University of South Florida and Cedars-Sinai Medical Center. An article in the Journal of Cellular and Molecular Medicine is available online.
Short arms and legs linked to risk of dementia
People with shorter arms and legs may be at a higher risk for developing dementia later in life compared to people with longer arms and legs, according to a study published in the May 6, 2008, bonus issue of Neurology, the medical journal of the American Academy of Neurology. Researchers say the association between short limbs and dementia risk may be due to poor nutrition in early life, which can affect limb growth.

News discussion:

Medicine & Health news